$25.14
▼ -0.0% Today
as of Jul 22, 16:45 ET
Last 30 days
Recent Press Releases & News
AORT: Raising target price to $24.00
Below Expected Sales for AMDS Hurt Artivion (AORT) in Q2
AORT: Lowering target price to $22.00
Overview
52-week range
$19
$48
21% of range
Avg surprise (last 3)
+33.8%
Avg reaction (last 2)
+1.9%
100% positive
Latest IV / EM
78%
EM ±17.8% · $25 · Aug 21
Earnings trends
EPS — actual vs estimate
Actual Estimate
Revenue vs Net Income
Revenue Net income
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Thu May 7, 2026 | Mar/2026 | $0.08 | $0.06 | +33.3% | +33.3% | +2.0% | earnings |
| Tue Sep 30, 2025 | Sep 2025 | $0.13 | — | — | — | — | financials |
| Thu Aug 7, 2025 | Jun/2025 | $0.24 | $0.11 | +118.2% | — | — | earnings |
| Mon May 5, 2025 | Mar/2025 | $0.06 | $0.12 | -50.0% | — | +1.9% | earnings |
| Mon Sep 30, 2024 | Sep 2024 | $-0.05 | — | — | — | — | financials |
| Sun Jun 30, 2024 | Jun 2024 | $-0.05 | — | — | — | — | financials |
| Sun Mar 31, 2024 | Mar 2024 | $0.18 | — | — | — | — | financials |
| Sat Sep 30, 2023 | Sep 2023 | $-0.24 | — | — | — | — | financials |
| Fri Jun 30, 2023 | Jun 2023 | $-0.08 | — | — | — | — | financials |
Upcoming
| Date | Fiscal | Time | EPS Est | LY EPS | YoY %Δ |
|---|---|---|---|---|---|
| Thu Aug 6, 2026 | Jun/2026 | OTHER | $0.13 | $0.24 | -45.8% |
Financials
Income statement (quarterly)
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — |
| Cost of revenue | — | — | — | — | — | — | — | — |
| Gross profit | $75M | — | $74M | $73M | $64M | — | $61M | $63M |
| Operating income | $6M | — | $13M | $8M | $2M | — | $4M | $7M |
| Net income | $1M | — | $7M | $1M | $-505,000 | — | $-2M | $-2M |
| EPS (diluted) | $0.03 | — | $0.13 | $0.03 | $-0.01 | — | $-0.05 | $-0.05 |
Balance sheet (quarterly)
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $56M | $65M | $73M | $53M | $38M | $53M | $56M | $55M |
| Inventory | $98M | $92M | $91M | $87M | $82M | $80M | $84M | $81M |
| Total current assets | $358M | $358M | $337M | $319M | $287M | $290M | $288M | $285M |
| Total assets | $883M | $885M | $858M | $838M | $791M | $789M | $803M | $790M |
| Long-term debt | $215M | $215M | $215M | $216M | $315M | $314M | $214M | $313M |
| Total liabilities | $433M | $437M | $419M | $418M | $497M | $513M | $498M | $494M |
| Total equity | $450M | $448M | $439M | $420M | $294M | $276M | $305M | $295M |